http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021209589-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_945d4c89a1c990a5c2267972d97e1a37 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-685 |
| filingDate | 2021-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cae2d96173074cef45602a6743d1ffb |
| publicationDate | 2021-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2021209589-A1 |
| titleOfInvention | Phospholipids and phospholipid metabolites for treating viral and bacterial pneumonia and sepsis |
| abstract | The invention relates to lysophosphatidylcholine (LysoPC), or a suitable precursor or derivative thereof, or a composition containing LysoPC and/or one or more suitable precursors or derivatives thereof, for use in the treatment and aftertreatment of human inflammatory diseases associated with a decrease in LysoPC levels, including the treatment, prevention, or treatment support and aftertreatment support of viral and bacterial pneumonia and sepsis, including pneumonia and sepsis as a result of influenza, Covid-19, ARDS, cancer, to support the efficacy of immunotherapy for cancer and to reduce side effects such as pneumonitis, colitis or hepatitis, and to reduce vaccine reactions. The invention also relates to alpha-glycerophosphocholine (alpha-GPC) or a variant thereof, or a composition comprising alpha-GPC and/or one or more variants thereof, for use in the treatment and aftertreatment of cancer and tumour cachexia. |
| priorityDate | 2020-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 198.